FindTrial
Sign In

To identify factors responsible for intensive care admission and death in patients suffering from acute febrile illness

Predictors of Intensive Care Unit Admission and Mortality in Acute Febrile Illness: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/024355
Enrollment
100
Registered
2020-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A90- Dengue fever [classical dengue] Health Condition 2: A91- Dengue hemorrhagic fever Health Condition 3: A270- Leptospirosis icterohemorrhagica Health Condition 4: B508- Other severe and complicated Plasmodium falciparum malaria Health Condition 5: B500- Plasmodium falciparum malaria withcerebral complications Health Condition 6: B509- Plasmodium falciparum malaria, unspecified Health Condition 7: B518- Plasmodium vivax malaria with other complications Health Condition 8: B

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: AFI patients of age >12years within 24 hours of presentation to Hospital Informed written consent

Exclusion criteria

Exclusion criteria: Exclusion criteria: Refusal to consent for study Pre-existing chronic organ dysfunction Presented to hospital for >24hours Age

Design outcomes

Primary

MeasureTime frame
To identify the risk factors of ICU admission of AFI patients admitted to ED Timepoint: 28 days—

Secondary

MeasureTime frame
To identify the risk factors of-In hospital mortality To assess if APACHE II, qSOFA, SOFA score and 24 hour lactate clearance can predict adverse outcomes (Length of stay in ICU and Length of stay in hospital, Organ dysfunction, requirement of organ support)Timepoint: 28 days—

Countries

India

Contacts

Public ContactDr Srikant Behera

AIIMS, New Delhi

dalimkumar.ab8@gmail.com08917219537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026